The board of Aspen Pharmacare Holdings Limited announced that it has appointed Ms. Babalwa Ngonyama to succeed Mr. John Buchanan as the chairman of the company's Audit & Risk Committee with effect from 1 January 2018. Mr. Buchanan, who has expressed his intention to retire as a director of the company during the 2018 calendar year, will remain a member of this Committee.